Alegeus recently announced it will donate a total of $20,000 to three charities chosen by employees as part of its 2015 holiday giving program. Instead of spending on corporate gifts and holiday cards, Alegeus decided to allow workers to showcase a charity of their preference via a page on the corporate…
People with Parkinson’s disease have a higher risk of bad falls and hip fractures as early as 26 years before diagnosis, partly because of a poorer sense of balance that might be an early sign of the illness, according to a study published in the journal PLOS Medicine and titled “Risk of Injurious…
Mayo Clinic researchers in Arizona and Banner Sun Health Research Institute have found that a biopsy of a portion of a person’s submandibular gland may be a feasible approach to diagnose early Parkinson’s disease. The research is published in the journal Movement Disorders and titled “Peripheral…
Researchers report that a single hand-exercise session, lasting just 15 minutes, improved both manual dexterity and movement in patients with Parkinson’s disease, helping them carry out basic tasks like writing a note or a buttoning shirt. The study, “Effects of a Single Hand–Exercise Session on Manual Dexterity and Strength in Persons…
Physiotherapy and occupational therapy do not improve the quality of life for patients with mild to moderate Parkinson’s disease (PD), according to a new study published in JAMA Neurology. The findings were based on a large-scale clinical trial, PD REHAB, conducted by researchers at the…
Simvastatin, a cholesterol lowering drug, will be investigated as a potential treatment option for Parkinson’s disease (PD) patients. Researchers hope this drug might one day effectively treat the disease. The double-blinded placebo-controlled clinical trial, in development at the Plymouth University Peninsula Schools of Medicine and Dentistry, plans to enroll up to 198 PD patients at 21 U.K. centers. Researchers are considering…
A drug typically prescribed for dementia may help prevent debilitating falls in people with Parkinson’s disease, according to a study, “Rivastigmine for gait stability in patients with Parkinson’s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial,” published in the journal The Lancet Neurology. Falls are a frequent…
An analysis from business intelligence provider GBI Research titled “Frontier Pharma: Parkinson’s Disease — Identifying and Commercializing First-in-Class Innovation,” claims the current Parkinson’s disease (PD) treatment market relies on neuromodulators, and even though symptoms might be soothed, no neuromodulator has demonstrated neuroprotective properties to prevent or even slow…
A recent study published in JAMA Neurology suggested an association between weight loss in patients with early Parkinson’s disease and rapid disease progression. Weight loss is usual in patients with Parkinson’s disease (PD), but these new findings indicate that weight loss early in the disease’s progression reflects a more serious form…
Parkinson’s News Today regularly reports the latest news on clinical trials, state-of-the-art research, and events related to Parkinson’s disease. With 2015 at a close, Parkinson’s News Today brings you the past year’s Top 10 Parkinson’s Disease Stories as determined by the number of views given each article by readers. No.
Get regular updates to your inbox.